Prestige Biologics amends annual report to add block tagging to financial statement notes
Bitget2026/09/28 06:29- Prestige Biologics filed a corrected annual report for FY2026 ended June 30, 2026, dated Sept. 28.
- The correction applied block-tagging to selected financial statement notes, including company overview, basis of preparation, and key accounting policies.
- No changes were disclosed to the underlying financial figures, business description, or other substantive report content.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The EU questions why a certain exchange continues to operate after being asked to exit

How Strategy keeps STRC near $100 while MSTR stock swings
WTI Crude Oil Drops Over 1.00% Today, Currently at $88.55 per Barrel
Summary of the Bank of Japan's September meeting opinions: Majority of members advocate for continued rate hikes, some call for acceleration.
The summary of the Bank of Japan's September meeting opinions shows that some policymakers believe it is necessary to accelerate interest rate hikes or bring rates closer to the central bank's "target" as soon as possible, increasing the likelihood of further rate hikes.